Skip to main content

Diagnostic options Β· UAE

Biochemistry tests in Dubai & UAE

Compare available Biochemistry tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

1,113

Listed price range

450.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Biochemistry test prices

Showing 706–720 of 1,113 matching tests.

Biochemistry diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-2670
Nicotine and Cotinine Urine Test

This test quantifies nicotine and cotinine levels in urine to provide definitive evidence of tobacco exposure or NRT compliance.

Urine 2–3 weeks from sample receipt 1,900.00 AED
View
View test specifications and preparation
What it measures
["Nicotine", "Cotinine"]
Parameters
[{"name": "Nicotine", "reference_range": null}, {"name": "Cotinine", "reference_range": null}]
Preparation
[]
Indications
["Verifying smoking cessation", "Informing insurance risk assessments", "Monitoring NRT compliance", "Pre-employment screening"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 56519-2 ICD-10: Z72.0, F17.2, Z87.891
Clinical summary
This test quantifies nicotine and cotinine levels in urine to provide definitive evidence of tobacco exposure or NRT compliance.
TEST-456
NIPT Advanced 23-Chromosome Panel Test

This test evaluates cell-free fetal DNA in maternal blood to screen for common chromosomal aneuploidies.

Peripheral whole blood (maternal plasma) 5–7 business days 2,400.00 AED
View
View test specifications and preparation
What it measures
["Cell-free fetal DNA (cfDNA)", "Trisomy 21", "Trisomy 18", "Trisomy 13", "Autosomal aneuploidies", "Sex aneuploidies"]
Parameters
[]
Preparation
["No fasting required"]
Indications
["Screening for common fetal aneuploidies", "Singleton pregnancies from 10 weeks gestation"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82106-5 ICD-10: Z13.89
Clinical summary
This test evaluates cell-free fetal DNA in maternal blood to screen for common chromosomal aneuploidies.
TEST-1298
NIPT Microdeletion Screening Test

This test screens for common fetal microdeletion syndromes using cell-free fetal DNA from maternal blood.

Peripheral whole blood (maternal venous blood) 8–10 working days 2,400.00 AED
View
View test specifications and preparation
What it measures
["Cell-free fetal DNA (cffDNA)", "Microdeletion syndromes (22q11.2, 1p36, Cri-du-Chat, Prader-Willi/Angelman, Wolf-Hirschhorn)"]
Parameters
[]
Preparation
["No specific fasting required", "No medication changes needed"]
Indications
["Singleton pregnancies β‰₯10 weeks gestation", "Screening for specific microdeletion syndromes"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82659-0 ICD-10: Z36.2
Clinical summary
This test screens for common fetal microdeletion syndromes using cell-free fetal DNA from maternal blood.
TEST-3991
NKX2-1 Gene Hereditary Benign Chorea Genetic Test

This test evaluates the NKX2-1 gene for pathogenic mutations associated with hereditary benign chorea.

Whole Blood (Peripheral) or Dried Blood Spot (FTA Card) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic mutations in the NKX2-1 gene", "Exonic regions Β±20bp intronic borders of the NKX2-1 gene"]
Parameters
[]
Preparation
["No specific physical preparation needed", "Have family medical history information available for genetic counselling"]
Indications
["Suspected hereditary benign chorea", "Differential diagnosis of chorea", "Familial risk assessment"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 49266-4 ICD-10: G25.5
Clinical summary
This test evaluates the NKX2-1 gene for pathogenic mutations associated with hereditary benign chorea.
TEST-4481
NLRP1 Gene Autoimmune Susceptibility Genetic Test

This genetic test evaluates the NLRP1 gene for variants associated with autoimmune susceptibility, particularly vitiligo.

Peripheral blood, buccal swab, or FTA card 4 to 5 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["NLRP1 gene variants", "Genetic susceptibility to autoimmune conditions"]
Parameters
[]
Preparation
["No special fasting is needed"]
Indications
["Refining diagnosis of autoimmune disorders", "Assessing familial risk", "Guiding autoimmune surveillance protocols"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82939-0 ICD-10: L80, Z13.89
Clinical summary
This genetic test evaluates the NLRP1 gene for variants associated with autoimmune susceptibility, particularly vitiligo.
TEST-3619
NLRP1 Gene Corneal Intraepithelial Dyskeratosis and Ectodermal Dysplasia NGS Test

This diagnostic test evaluates the NLRP1 gene for pathogenic variants associated with corneal intraepithelial dyskeratosis and ectodermal dysplasia.

Peripheral Whole Blood (also accepts extracted DNA / FTA card) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy number variations (CNVs)"]
Parameters
[]
Preparation
[]
Indications
["Diagnosis of corneal intraepithelial dyskeratosis", "Diagnosis of ectodermal dysplasia", "Familial risk assessment for at-risk relatives"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94222-8 ICD-10: Q82.4, H18.89
Clinical summary
This diagnostic test evaluates the NLRP1 gene for pathogenic variants associated with corneal intraepithelial dyskeratosis and ectodermal dysplasia.
TEST-5321
NLRP12 Gene Sequencing for Cold Autoinflammatory Syndrome Type 2 (CAPS2) Test

This diagnostic test evaluates the NLRP12 gene for pathogenic variants associated with Cold Autoinflammatory Syndrome Type 2 (CAPS2).

Whole Blood (EDTA) or Buccal Swab 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["NLRP12 gene coding region", "Pathogenic variants (SNVs, indels, CNVs, deep intronic variants)"]
Parameters
[]
Preparation
["No fasting required", "Standard hygiene protocols for phlebotomy apply"]
Indications
["Suspected Cold Autoinflammatory Syndrome Type 2 (CAPS2)", "Hereditary periodic fever syndrome"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 98238-5 ICD-10: M04.2
Clinical summary
This diagnostic test evaluates the NLRP12 gene for pathogenic variants associated with Cold Autoinflammatory Syndrome Type 2 (CAPS2).
TEST-6398
NNT Gene Glucocorticoid Deficiency Type 4 (With or Without Mineralocorticoid Deficiency) Test

This test identifies genetic mutations in the NNT gene responsible for hereditary glucocorticoid deficiency type 4.

Whole Blood (EDTA), Extracted Genomic DNA, or FTA Card 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["NNT gene sequence", "Pathogenic variants (SNVs, indels, CNVs)"]
Parameters
[]
Preparation
["No fasting or medication adjustments required", "Mandatory pre-test genetic counselling session"]
Indications
["Suspected Glucocorticoid Deficiency Type 4", "Confirmation of diagnosis in patients with relevant clinical and biochemical findings"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81247-7 ICD-10: E27.1, E27.40, Z13.228
Clinical summary
This test identifies genetic mutations in the NNT gene responsible for hereditary glucocorticoid deficiency type 4.
TEST-515
Non-Invasive Prenatal Test (NIPT) for Twins

This test screens for common fetal chromosomal abnormalities (trisomy 21, 18, 13) in twin pregnancies using cell-free DNA from maternal blood.

Peripheral Whole Blood (Maternal) 8–10 Working Days 2,000.00 AED
View
View test specifications and preparation
What it measures
["Cell-free fetal DNA (cffDNA)", "Fetal fraction per fetus"]
Parameters
[]
Preparation
["No specific fasting required", "Do not discontinue prescribed medication without consulting your doctor"]
Indications
["Twin pregnancy", "Screening for common fetal chromosomal abnormalities"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 77649-1 ICD-10: Z36.2
Clinical summary
This test screens for common fetal chromosomal abnormalities (trisomy 21, 18, 13) in twin pregnancies using cell-free DNA from maternal blood.
TEST-512
Non‑Invasive Prenatal Paternity DNA Test

This test determines biological fatherhood by analyzing cell-free fetal DNA from maternal blood against the alleged father's DNA.

Maternal Peripheral Blood (Plasma) + Alleged Father Buccal Swab or Blood 10–12 Working Days (Express 7 Days Available) 7,000.00 AED
View
View test specifications and preparation
What it measures
["Cell-free fetal DNA (cffDNA)", "Single Nucleotide Polymorphisms (SNPs)"]
Parameters
[]
Preparation
["Do not discontinue or adjust any prescribed medication without consulting your treating doctor.", "Maintain all existing treatment schedules during the testing window."]
Indications
["Establishing paternity during pregnancy", "Legal paternity determination", "Family law matters"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82719-9 ICD-10: Z36.89, Z31.5
Clinical summary
This test determines biological fatherhood by analyzing cell-free fetal DNA from maternal blood against the alleged father's DNA.
TEST-2678
Nortriptyline Test

This diagnostic test evaluates the concentration of nortriptyline in the patient's serum.

Serum 2–3 weeks (batch‑optimised) 1,800.00 AED
View
View test specifications and preparation
What it measures
["Serum Nortriptyline Concentration"]
Parameters
[{"name": "Nortriptyline", "reference_range": "50-150 ng/mL"}]
Preparation
["Collect serum >12 hours after your last oral dose", "Use a plain red-top tube only", "Submit a signed consent form (Form 35)"]
Indications
["Monitoring therapeutic drug levels", "Adjusting dosage", "Ruling out overdose", "Assessing compliance"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 2074-0 ICD-10: Z79.89
Clinical summary
This diagnostic test evaluates the concentration of nortriptyline in the patient's serum.
TEST-3769
NOS3 (eNOS) Gene Alzheimer's Disease Susceptibility Test (NGS)

This test evaluates variants in the NOS3 gene associated with increased susceptibility to Alzheimer's disease.

Peripheral whole blood or FTA card (buccal swab acceptable after consultation) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["NOS3 gene variants", "Endothelial nitric oxide synthase (eNOS) function related to cerebral blood flow"]
Parameters
[]
Preparation
[]
Indications
["Risk assessment for late-onset Alzheimer's disease", "Personalized risk reduction strategies", "Integration with clinical assessment for neurological conditions"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21632-5 ICD-10: Z13.82
Clinical summary
This test evaluates variants in the NOS3 gene associated with increased susceptibility to Alzheimer's disease.
TEST-2697
NOTCH3 Mutation Detection (CADASIL) Test

This test detects pathogenic mutations in the NOTCH3 gene associated with CADASIL.

Peripheral Whole Blood (EDTA) 5 Business Days 1,800.00 AED
View
View test specifications and preparation
What it measures
["NOTCH3 gene pathogenic variants", "CADASIL genetic predisposition"]
Parameters
[]
Preparation
["No fasting required", "Continue all prescribed medications"]
Indications
["Suspected CADASIL based on clinical presentation", "Family history of CADASIL", "Recurrent ischemic events in young adults"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94212-5 ICD-10: I67.85
Clinical summary
This test detects pathogenic mutations in the NOTCH3 gene associated with CADASIL.
TEST-3621
NPHP1 Gene (Nephronophthisis Typeβ€―1) Genetic Test

This test identifies pathogenic variants in the NPHP1 gene associated with nephronophthisis type 1.

Peripheral whole blood (EDTA), extracted DNA, or FTA card 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["DNA sequence variants in the NPHP1 gene", "Copy Number Variations (CNV) in the NPHP1 gene"]
Parameters
[]
Preparation
["Genetic counselling session required before sample collection", "Fasting is not required"]
Indications
["Suspected nephronophthisis type 1", "Family history of nephronophthisis", "Evaluation of childhood kidney disease"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: Q61.8
Clinical summary
This test identifies pathogenic variants in the NPHP1 gene associated with nephronophthisis type 1.
TEST-3637
NPHS1 Gene Nephrotic Syndrome Type 2 Genetic Test

This test detects pathogenic variants in the NPHS1 gene associated with congenital nephrotic syndrome of the Finnish type.

Peripheral Whole Blood (EDTA) or Extracted DNA 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the NPHS1 gene", "Copy Number Variations (CNV) in the NPHS1 gene"]
Parameters
[]
Preparation
["No special preparation required", "Mandatory pre-test genetic counselling session"]
Indications
["Suspected congenital nephrotic syndrome of the Finnish type", "Family history of NPHS1-related nephrotic syndrome", "Early-onset nephrotic syndrome"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81430-7 ICD-10: N04.9
Clinical summary
This test detects pathogenic variants in the NPHS1 gene associated with congenital nephrotic syndrome of the Finnish type.

Category overview

Biochemistry: overview

Seeking clarity about your body's essential functions is vital for long-term well-being. At DNA Labs UAE, our Biochemistry services utilize advanced automated analyzers to evaluate enzymes, proteins, and metabolites in your blood. Whether you need routine metabolic panels or specialized biochemical testing in the UAE, these tests provide critical data to guide your physician's medical plan. As a leading diagnostic lab in Dubai and the UAE, we guarantee strict confidentiality and rapid, accurate turnaround times. Take charge of your health today. Explore our biochemistry diagnostics below, schedule a convenient home sample collection, or contact our specialists to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area